Kumar Namdev
Global Head, CMC Product development and industrialization, mRNA Center of Excellence @ Sanofi
Kumar Namdev heads CMC Development and Industrialization in mRNA Center of Excellence in Sanofi. Kumar has more than 25 years of experience in CMC development, technology transfer, validation, licensure and life cycle management of biologics and vaccines. He has been in Sanofi for 14 years where previously he held roles to lead local and global technical func7ons to support launch of several new biologic products such as Dupixent, develop several next genera7on manufacturing processes and implement more than a dozen products in multiple internal and external manufacturing facilities for commercial supply.